Semnur Pharmaceuticals, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $4.2M | $86.3M | $0 |
| FY2023 | $8.5M | $50.7M | $204.5K |
| FY2024 | $49.5M | $6.7M | $12.0K |
| FY2025 | $22.1M | $1.3M | $20.0K |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | $4.2M | $86.3M | $0 |
| FY2023 | $8.5M | $50.7M | $204.5K |
| FY2024 | $49.5M | $6.7M | $12.0K |
| FY2025 | $22.1M | $1.3M | $20.0K |